Stocks · Health care · Biological Products, (No Diagnostic Substances)

Amgen

AMGN Clue Score50
United States Fiscal year ends December CIK 0000318154 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Robert A Bradway
4 Mar 2026
Chairman, CEO and President
Exercised, kept
119,782
$156.35
$18.73M
Robert Eckert
10 Aug 2022
Director
Exercised, kept
20,000
$85.59
$1.71M
Robert A Bradway
18 Feb 2021
Chairman, CEO and President
Exercised, kept
73,500
$54.69
$4.02M
David M Reese
16 Feb 2021
EVP, Research and Development
Exercised, kept
2,300
$54.69
$125.79K
Robert A Bradway
13 Apr 2020
Chairman, CEO and President
Exercised, kept
84,000
$58.43
$4.91M
Robert A Bradway
13 Apr 2020
Chairman, CEO and President
Exercised, kept
43,000
$58.43
$2.51M
David Piacquad
20 Nov 2019
SVP, Business Development
Exercised, kept
5,749
$156.35
$898.86K
David Piacquad
30 Nov 2018
SVP, Business Development
Exercised, kept
6,500
$54.69
$355.49K
Rebecca M Henderson
10 Aug 2018
Director
Exercised, kept
3,000
$63.11
$189.33K
David Piacquad
11 May 2018
SVP, Business Development
Exercised, kept
15,000
$54.71
$820.65K

What was left out

Form 4 filings counted 780
Amendments (4/A) skipped 0
Filings about a different issuer 10
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 39
Sales at will 47
Transactions with no price 0
Shares from compensation/vesting 3,398,323
Sales filed before the plan box existed 31
History held since 4 Oct 2006